Bansk Group Extends Investment in Arcadia Consumer Healthcare via Continuation Fund

January 20, 2026

Bansk Group closed a continuation fund to extend its partnership with Arcadia Consumer Healthcare, with the transaction co-led by Coller Capital and Ares Secondaries Funds and supported by investment funds managed by BlackRock, Churchill, Dextra Partners, and Future Standard. The continuation structure provided liquidity to existing investors and supplies capital to accelerate Arcadia's organic and inorganic growth across its portfolio of OTC medicines, vitamins, and personal care brands.

Buyers
Bansk Group, Coller Capital, Ares Secondaries Funds (Ares Management), Investment funds managed by BlackRock, Churchill, Dextra Partners, Future Standard
Targets
Arcadia Consumer Healthcare
Sellers
Existing Arcadia investors
Location
New Jersey, United States
Transaction Type
Recapitalization

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.